Evaluation of the Protective Effects of Sarains on H2O2-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Neuroblastoma Cells
Loading...
Identifiers
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Abstract
Sarains are diamide alkaloids isolated from the
Mediterranean sponge Haliclona (Rhizoniera) sarai that have
previously shown antibacterial, insecticidal and anti-fouling
activities. In this study, we examined for the first time the
neuroprotective effects of sarains 1, 2 and A against oxidative
stress in a human neuronal model. SH-SY5Y cells were coincubated with sarains at concentrations ranging from 0.01 to
10 μM, and the well-known oxidant hydrogen peroxide at
150 μM for 6 h and the protective effects of the compounds
were evaluated. Among the sarains tested, sarain A was the
most promising compound, improving mitochondrial function
and decreasing reactive oxygen species levels in human neuroblastoma cells treated with the compound at 0.01, 0.1 and
1 μM. This compound was also able to increase the activity of
the antioxidant enzymes superoxide dismutases by inducing
the translocation of the nuclear factor E2-related factor 2
(Nrf2) to the nucleus at the lower concentrations tested (0.01
and 0.1 μM). Moreover, sarain A at 0.1 and 1 μM blocked the
mitochondrial permeability transition pore (mPTP) opening
through cyclophilin D inhibition. These results suggest that
the protective effects produced by the treatment with sarain
A are related with its ability to block the mPTP and to enhance
the Nrf2 pathway, indicating that sarain A may be a candidate
compound for further studies in neurodegenerative diseases
Description
Keywords
Bibliographic citation
Alvariño, R., Alonso, E., Tribalat, MA. et al. Evaluation of the Protective Effects of Sarains on H2O2-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Neuroblastoma Cells. Neurotox Res 32, 368–380 (2017)
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1007/s12640-017-9748-3Sponsors
The research leading to these results has received
funding from the following FEDER cofunded-grants. From CDTI and
Technological Funds, supported by Ministerio de Economía, Industria y
Competitividad, AGL2014-58210-R, AGL2016-78728-R (AEI/FEDER,
UE), ISCIII/PI16/01830 and RTC-2016-5507-2. From CDTI under ISIP
Programme, Spain, IDI-20130304 APTAFOOD and ITC-20161072.
From the European Union’s Seventh Framework Programme managed
by REA – Research Executive Agency (FP7/2007-2013) under grant
agreement 312184 PHARMASEA
Rights
Atribución 4.0 Internacional








